24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oic acid,3-hydroxy-9,13-dimethyl-2-oxo-, (9b,13a,14b,20a)-
CAS: 34157-83-0
Ref. IN-DA00I6R1
1g | Ausgelaufen | ||
5g | Ausgelaufen | ||
100mg | Ausgelaufen | ||
250mg | Ausgelaufen | ||
500mg | Ausgelaufen |
- Arzneimittelwirkstoffe (API) zugehörige Verbindungen
- Arzneimittelwirkstoffe (API) für Forschungszwecke
- Antibiotika
- Biochemikalien und Reagenzien
- Krebsforschung
- Zelluläre und molekulare Biologie
- Enzymaktivatoren und -hemmstoffe
- Naturprodukte und phytochemische Stoffe botanischen Ursprungs
- Ernährungsforschung
- Andere Inhibitoren
- Phytochemikalien
- Steroide
- Terpenoide
- Triterpene (C₃₀)
Produktinformation
Name:
24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oic acid,3-hydroxy-9,13-dimethyl-2-oxo-, (9b,13a,14b,20a)-
Synonyme:
- [u'celastrol', u'tripterine', u'celastrol', u'34157-83-0', u'Tripterine', u'Tripterin', u'(2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid', u'Celastrol, Celastrus scandens', u'UNII-L8GG98663L', u'C29H38O4', u'NSC70931', u'NSC 70931', u'CHEBI:63959', u'3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid', u'L8GG98663L', u'MFCD03424073', u'(2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid', u'D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20alpha)-', u'SR-05000002679', u'MLS002701906', u'triterpene', u'Spectrum_000335', u'Spectrum2_000150', u'Spectrum3_000233', u'Spectrum4_001966', u'Spectrum5_000805', u'AC1L3V4O', u'SCHEMBL14954', u'BSPBio_001905', u'KBioGR_002436', u'KBioSS_000815', u'SPECTRUM201664', u'MLS006011086', u'DivK1c_000718', u'SPBio_000260', u'AC1Q6P61', u'DTXSID2040993', u'KBio1_000718', u'KBio2_000815', u'KBio2_003383', u'KBio2_005951', u'KBio3_001405', u'KQJSQWZMSAGSHN-JJWQIEBTSA-N', u'NINDS_000718', u'BDBM205457', u'HMS1923A13', u'HMS3649E12', u'BCP07973', u'EBD30960', u'CC0152', u'CCG-39919', u'NSC-70931', u's1290', u'ZINC19795938', u'Celastrol, >=98% (HPLC), solid', u'AKOS025311497', u'AC-6031', u'API0001923', u'CS-0409', u'GS-6082', u'IDI1_000718', u'NCGC00178913-01', u'NCGC00178913-04', u'HY-13067', u'NCI60_038570', u'S492', u'SC-19832', u'SMR004702874', u'LS-157465', u'N1731', u'ST24050307', u'W-5302', u'157C830', u'Q-100413', u'SR-05000002679-1', u'SR-05000002679-3', u'SR-05000002679-4', u'(20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oate', u'(20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid', u'(2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid', u'1,2,3,4,4a,5,6,6a, 11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b, 14a-hexamethyl-11-oxo-2-Picenecarboxylic acid', u'10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid', u'2-Picenecarboxylic acid,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-', u'3-Hydroxy-9.beta.,13.alpha.-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid', u'3-hydroxy-9beta,13alpha-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid', u'D0I9XH', u'C12H16NS.Br', u'2,5-Dibromo-4-methylpyridine', u'CHEMBL301982', u'C12-H16-N-S.Br', u'KST-1A4115', u'AR-1A3014', u'CID122724', u'ACN-035486', u'C29-H38-O4', u'A2604', u'C2737', u'C050414', u'Celastrol, 98%, Protease inbibitor - 25MG 25mg', u'35327-72-1', u'1H-Pyrido(2,1-b)benzothiazolium, 2,3,4,4a-tetrahydro-10-methyl-, bromide', u'2,3,4,4a-Tetrahydro-10-methyl-1H-pyrido(2,1-b)benzothiazolium bromide', u'4a-Methyl-1,2,3,4,4a,10-hexahydropyrido(2,1-b)benzothiazolyl bromide']
- (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid
- (2R,4aS,6aS,6aR,14aS,14bR)-10-Hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid
- (9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
- 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-
- 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, [2R-(2α,4aβ,6aβ,12bβ,14aα,14bβ)]-
- 24,25,26-Trinoroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-9,13-dimethyl-2-oxo-, (9β,13α,14β,20α)-
- 24-Nor-D:A-friedooleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-
- D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20α)-
- NSC 70931
- Mehr Synonyme anzeigen
- Tripterin
- Ui1590
- Celastrol
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Indagoo
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
450.6096
Formel:
C29H38O4
Reinheit:
98%
Farbe/Form:
Solid
InChl:
InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1
InChI Key:
KQJSQWZMSAGSHN-JJWQIEBTSA-N
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code: